- Repligen Corporation (NASDAQ:RGEN) Street Rating in Focus
- There are 4 equity research firms tracked by Zacks that cover shares of Repligen Corporation (NASDAQ:RGEN). The sell-side analysts offer Buy,Sell or Hold recommendations on the stock. Zacks translates the recommendations into an average numerical ...
- $0.12 EPS Expected for Repligen Co. (NASDAQ:RGEN) This Quarter
- Repligen logo Wall Street brokerages expect Repligen Co. (NASDAQ:RGEN) to post earnings per share (EPS) of $0.12 for the current quarter, according to Zacks Investment Research.
- Zacks: Analysts Anticipate Repligen Co. (NASDAQ:RGEN) to Post $0.12 EPS
- Repligen logo Analysts expect that Repligen Co. (NASDAQ:RGEN) will report earnings of $0.12 per share for the current quarter, Zacks reports.
- Repligen's (RGEN) CEO Tony Hunt on Q4 2015 Results - Earnings Call Transcript
- Good day, ladies and gentlemen and welcome to the Repligen Corporation's Fourth Quarter and Full Year 2015 Earnings Conference Call. My name is Kat and I will be your coordinator. At this time all participants are in a listen-only mode.
- Repligen Co. (RGEN) Stock Rating Lowered by Zacks Investment Research
- Several other equities analysts have also commented on RGEN. Jefferies Group lowered Repligen from a “buy” rating to a “hold” rating in a research note on Friday, November 6th. Craig Hallum started coverage on Repligen in a research note on Monday, ...
Rgen is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Rgen books and related discussion.